ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 695,78
0,83%
Dow Jones
39 308,00
-0,06%
DAX
18 450,48
0,38%
Brent Oil
87,33
0,48%
Bitcoin
58 142,95
-3,36%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Entasis Therapeutics Holdings Inc (ETTX)

  7. Entasis Therapeutics Holdings Inc (ETTX) Actualités

ETTX

Entasis Therapeutics (ETTX)

Entasis Therapeutics Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ETTX
DateHeureSourceTitreSymboleSociété
12/10/202214h30GlobeNewswire Inc.Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022NASDAQ:ETTXEntasis Therapeutics Holdings Inc
21/07/202223h28Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
11/07/202223h27Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
11/07/202223h17Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
11/07/202223h13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
11/07/202222h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/07/202223h05Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/07/202223h02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/07/202222h49Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/07/202214h35Business WireInnoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.NASDAQ:ETTXEntasis Therapeutics Holdings Inc
07/06/202215h05Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
25/05/202200h36PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Entasis Therapeutics Holdings Inc.NASDAQ:ETTXEntasis Therapeutics Holdings Inc
23/05/202222h19Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
23/05/202222h17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
02/05/202222h06Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
27/04/202222h19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
27/04/202212h16TipRanksEntasis Therapeutics Holdings (ETTX) Gets a Hold Rating from H.C. WainwrightNASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/03/202213h32TipRanksWedbush Downgrades Entasis Therapeutics Holdings (ETTX) to HoldNASDAQ:ETTXEntasis Therapeutics Holdings Inc
04/03/202212h27TipRanksAnalyst Explains Why They Downgraded Their Rating on Entasis Therapeutics Holdings (ETTX)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
03/03/202222h07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
25/02/202223h05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
14/02/202217h44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
19/10/202115h00GlobeNewswire Inc.Zai Lab and Entasis Therapeutics Announce Positive Topline Results for Sulbactam-Durlobactam (SUL-DUR) from Phase 3 ATTACK TrialNASDAQ:ETTXEntasis Therapeutics Holdings Inc
28/08/202100h08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
06/08/202112h12Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
02/08/202122h40Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
19/07/202122h06Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
17/06/202122h17Edgar (US Regulatory)Tender Offer Statement by Issuer (sc To-i)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
17/05/202117h03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
05/05/202122h46Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ETTX

Dernières Valeurs Consultées

BIT
AEMD
Amundi Ind Msci Emerging...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés